The overexpression of growth factor receptors (e.g., Met receptor, EGFR, and so on) and their downstream signalling such as PI-3 kinase has been reported in high-grade ovarian tumours (Stadlmann et al, 2006; Sawada et al, 2007). Here, EGFR is linked to ovarian neoplasm.